Lonza primary immune cells and media

Friday, 11 June, 2010 | Supplied by: Capsugel Australia Pty Ltd

Lonza primary immune cells and media

Lonza supplies a variety of primary cells isolated from normal peripheral blood, cord blood and bone marrow along with media specifically developed for culturing primary immune cells.

Cells are available to fit specific experimental needs, with a large selection of donors and lots and multiple immune cell types are available from the same donor.

Cells are processed to ensure highly homogeneous populations with high purity (≥85%) and viabilities of 100% of the stated cell number per product label.

Primary cells include: CD41+ monocytes, CD4+ T-cells, CD19+ B-cells, dendritic cells, NK cells, mononuclear cells.

LGM-3 Lymphocyte Growth Medium-3 was developed for the growth and support of human lymphocytes and dendritic cells.

Online: lonzabioscience.com.au
Phone: 1300 657508
Related Products

Amsbio StemFit Basic05 medium for scalable hPSC manufacturing

Compatible with both 2D adherent and 3D suspension culture, StemFit Basic05 enables a streamlined...

GeneTex carrier-free antibodies

GeneTex's carrier-fee antibodies are BSA-, sodium azide- and glycerol-free, featuring diverse...

Cayman Chemical LipidLaunch Ionizable Lipid LNP Screening Set

The LipidLaunch Ionizable Lipid LNP Screening Set is a screening set of 12 ionisable cationic and...


  • All content Copyright © 2026 Westwick-Farrow Pty Ltd